Jace C. Bradshaw, MD

Department of Emergency Medicine and Department of Anesthesiology and Critical Care Medicine

Johns Hopkins Hospital

$Angiotensin-Refractory-Shock-Featured-Image.jpg$

Critical Care

Critical Care: Angiotensin II for Management of Refractory Shock

12/8/2025 Vishnu Dontu , Rishab Agarwal , Jace C. Bradshaw, MD

Refractory shock is commonly managed with vasopressin, but it carries the risk of adverse side effects. Angiotensin II (Ang II) is gaining recognition as an alternative therapy.

CHAT NOW

CHAT OFFLINE